AKTX
Price
$1.15
Change
+$0.02 (+1.79%)
Updated
Jul 10 closing price
Capitalization
36.25M
MOLN
Price
$3.55
Change
-$0.04 (-1.11%)
Updated
Jul 10, 03:56 PM (EDT)
Capitalization
138.74M
46 days until earnings call
Interact to see
Advertisement

AKTX vs MOLN

Header iconAKTX vs MOLN Comparison
Open Charts AKTX vs MOLNBanner chart's image
Akari Therapeutics
Price$1.15
Change+$0.02 (+1.79%)
Volume$6.17K
Capitalization36.25M
Molecular Partners AG
Price$3.55
Change-$0.04 (-1.11%)
Volume$127
Capitalization138.74M
AKTX vs MOLN Comparison Chart in %
Loading...
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKTX vs. MOLN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a StrongBuy and MOLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (AKTX: $1.14 vs. MOLN: $3.55)
Brand notoriety: AKTX and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 31% vs. MOLN: 39%
Market capitalization -- AKTX: $36.25M vs. MOLN: $138.74M
AKTX [@Biotechnology] is valued at $36.25M. MOLN’s [@Biotechnology] market capitalization is $138.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileMOLN’s FA Score has 1 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 1 green, 4 red.
According to our system of comparison, AKTX is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 4 TA indicator(s) are bullish while MOLN’s TA Score has 1 bullish TA indicator(s).

  • AKTX’s TA Score: 4 bullish, 4 bearish.
  • MOLN’s TA Score: 1 bullish, 5 bearish.
According to our system of comparison, AKTX is a better buy in the short-term than MOLN.

Price Growth

AKTX (@Biotechnology) experienced а -2.14% price change this week, while MOLN (@Biotechnology) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

AKTX is expected to report earnings on Apr 15, 2025.

MOLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($139M) has a higher market cap than AKTX($36.2M). AKTX YTD gains are higher at: -6.148 vs. MOLN (-25.230). AKTX has higher annual earnings (EBITDA): -17.63M vs. MOLN (-57.15M). MOLN has more cash in the bank: 131M vs. AKTX (2.58M). AKTX has less debt than MOLN: AKTX (1.85M) vs MOLN (2.14M). MOLN has higher revenues than AKTX: MOLN (2.23M) vs AKTX (0).
AKTXMOLNAKTX / MOLN
Capitalization36.2M139M26%
EBITDA-17.63M-57.15M31%
Gain YTD-6.148-25.23024%
P/E RatioN/AN/A-
Revenue02.23M-
Total Cash2.58M131M2%
Total Debt1.85M2.14M86%
FUNDAMENTALS RATINGS
AKTX: Fundamental Ratings
AKTX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKTXMOLN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
AKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRZFF0.090.02
+23.29%
Boundary Gold & Copper Mng Ltd.
BXRBF6.30N/A
N/A
Bendigo & Adelaide Bank Ltd.
IFABF0.75N/A
N/A
iFabric Corp.
RYBIF15.00N/A
N/A
Ryobi Ltd.
SVNLY6.64-0.04
-0.56%
Svenska Handelsbanken AB PUBL

AKTX and

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
+2.14%
KPRX - AKTX
30%
Poorly correlated
+1.35%
DSGN - AKTX
24%
Poorly correlated
-3.12%
MOLN - AKTX
23%
Poorly correlated
-0.84%
GLTO - AKTX
23%
Poorly correlated
+2.06%
APVO - AKTX
22%
Poorly correlated
-0.99%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
-0.84%
SNSE - MOLN
42%
Loosely correlated
-0.55%
SLDB - MOLN
36%
Loosely correlated
-1.81%
RCKT - MOLN
33%
Poorly correlated
-1.25%
ATRA - MOLN
31%
Poorly correlated
+2.71%
RAPT - MOLN
30%
Poorly correlated
+2.13%
More